Why Racial Justice Matters in Radiation Oncology.


Journal

Advances in radiation oncology
ISSN: 2452-1094
Titre abrégé: Adv Radiat Oncol
Pays: United States
ID NLM: 101677247

Informations de publication

Date de publication:
Historique:
received: 08 06 2020
revised: 11 06 2020
accepted: 12 06 2020
pubmed: 25 8 2020
medline: 25 8 2020
entrez: 25 8 2020
Statut: ppublish

Résumé

Recent events have reaffirmed that racism is a pervasive disease plaguing the United States and infiltrating the fabric of this nation. As health care professionals dedicated to understanding and alleviating disease, many radiation oncologists have failed to acknowledge how structural racism affects the health and well-being of the patients we aim to serve. The literature is full of descriptive statistics showing the higher incidence and mortality experienced by the Black population for health conditions ranging from infant mortality to infectious disease, including coronavirus disease 2019 (COVID-19). Acknowledgment that the root of health disparities experienced by Black people in this country are based in racism is essential to moving the nation and the field of radiation oncology forward. With this lens, a brief overview of structural and institutional racism shapes a discussion of what radiation oncologists and the organizations that represent them can do to address this scourge. As members of a technological field, we often harness the power of data to advance human health and approach challenging diseases with optimism that multidisciplinary effort can produce cure. A few principles to mitigate the longstanding issues of Black marginalization within the field have been recommended via the ATIP (Acknowledgment, Transparency, Intentionality, and rePresentation) and LEADS (Learn, Engage, Advocate, Defend, Support) approaches. However, additional introspection is encouraged. Just as individuals, practices, and organizations rallied to determine how best to address the issues related to the COVID-19 pandemic, the same investigational fervor must be applied to the issue of racism to combat this sinister and often deadly disease.

Identifiants

pubmed: 32838067
doi: 10.1016/j.adro.2020.06.013
pii: S2452-1094(20)30162-7
pmc: PMC7340406
doi:

Types de publication

Journal Article

Langues

eng

Pagination

783-790

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2020 The Author(s).

Références

Am Soc Clin Oncol Educ Book. 2017;37:18-22
pubmed: 28561643
J Biomed Inform. 2016 Apr;60:104-13
pubmed: 26836975
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):912-8
pubmed: 23122983
BMC Biotechnol. 2019 Nov 29;19(1):84
pubmed: 31783836
Lancet. 2019 Jun 22;393(10190):2484-2485
pubmed: 31232362
J Prev Interv Community. 2013;41(4):220-30
pubmed: 24010559
Med Sci Monit. 2003 Mar;9(3):SR9-15
pubmed: 12640358
Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):900-1
pubmed: 23452453
N Engl J Med. 2016 Dec;375(22):2113-2115
pubmed: 27732126
Am Psychol. 2007 May-Jun;62(4):271-86
pubmed: 17516773
JAMA Oncol. 2018 Mar 1;4(3):289-290
pubmed: 29302685
Lancet. 2017 Apr 8;389(10077):1453-1463
pubmed: 28402827
Sci Transl Med. 2012 Mar 28;4(127):127ps8
pubmed: 22461638
Proc Natl Acad Sci U S A. 2019 Aug 20;116(34):16793-16798
pubmed: 31383756

Auteurs

Christina Hunter Chapman (CH)

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan.
Center for Clinical Management Research, VA Ann Arbor Healthcare System, Ann Arbor, Michigan.

Darlene Gabeau (D)

Department of Radiation Oncology, William E. Kahlert Regional Cancer Center, Lifebridge Health, Westminster, Maryland.

Chelsea C Pinnix (CC)

Department of Radiation Oncology, MD Anderson, Houston, Texas.

Curtiland Deville (C)

Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University, Baltimore, Maryland.

Iris C Gibbs (IC)

Department of Radiation Oncology, Stanford University, Stanford, California.

Karen M Winkfield (KM)

Department of Radiation Oncology, Wake Forest School of Medicine, Winston Salem, North Carolina.

Classifications MeSH